Bobby Gaspar, Orchard Therapeutics co-founder and CEO
Gene therapy maker Orchard Therapeutics sells to Kyowa Kirin for $387M cash as lead program awaits 2024 FDA verdict
Orchard Therapeutics’ gene therapies will have a new home as Japan’s Kyowa Kirin buys out the biotech for $387.4 million in cash.
Kyowa Kirin will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
